Abstract
The effect of adding different doses of Magnesium Sulphate to Bupivacaine in the ultrasound-guided supraclavicular brachial plexus block anesthesia.
Highlights
Pain is characterized as an unpleasant experience linked to the damage to the tissues
Supraclavicular brachial plexus block anesthesia. It is always the interest of the anesthetist to increase the quality of local anesthetics, so several studies have been done to evaluate the efficacy of adding different adjuvants to local anesthetics to prolong the block duration and reduce the toxicity, like opioids, magnesium sulphate, dexamethasone, hyaluronidase and neostigmine
Our study is the only one done to find the optimum lowest dose of magnesium sulphate as an adjuvant to bupivacaine in supraclavicular brachial plexus blocks giving the nearly same results as the large ones and the impact of that study on the economic factor up till
Summary
Pain is characterized as an unpleasant experience linked to the damage to the tissues. Aim of the work: Aim of this study is to evaluate the effect of adding different doses of magnesium sulphate to bupivacaine for supraclavicular brachial plexus block anesthesia. Results: Magnesium sulphate as an adjuvant to bupivacaine in supraclavicular brachial plexus blocks reduces the time to reach complete sensory and motor block and shortens the time before operation. Balanced or multimodal analgesia uses a combination of opioid and non-opioid analgesics to improve pain control These include the use of NSAIDs, local anesthetics and regional blocks. Any combination of these therapies can reduce the response to surgical stress and improve patient outcomes such as pain control, patient satisfaction and discharge time. One of methods used in this multimodal approach is the supraclavicular brachial plexus block anesthesia (Scott Urigel CRNA, 2014)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have